XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses        
General and administrative $ 2,434,127 $ 1,381,477 $ 6,138,528 $ 4,453,654
Research and development 8,964,528 6,725,002 23,610,888 19,126,717
Total operating expenses (11,398,655) (8,106,479) (29,749,416) (23,580,371)
Other income (expenses)        
Grant income 43,280 0 54,100 149,888
Research and development incentive income 1,363,661 1,319,913 3,593,856 2,980,456
Interest income, net 11,453 56,096 19,110 172,996
Foreign exchange gain (loss), net (160,880) 248,665 17,191 (24,182)
Total other income, net 1,257,514 1,624,674 3,684,257 3,279,158
Net loss before provision for income taxes (10,141,141) (6,481,805) (26,065,159) (20,301,213)
Income tax expense, current (39,000) (4,817) (125,269) (14,031)
Net loss and comprehensive loss $ (10,180,141) $ (6,486,622) $ (26,190,428) $ (20,315,244)
Net Loss per share        
Basic and diluted $ (0.14) $ (0.11) $ (0.39) $ (0.35)
Weighted average number of shares outstanding        
Basic and diluted 70,589,561 59,105,399 67,810,774 57,401,387